MAPT and Alzheimer disease: Despite their possible causative role, the consensus is that targeting amyloidosis, tau phosphorylation, acetylcholine esterase, glutamate, oxidative stress, and mitochondrial metabolism has not yet led to the development of drugs to cure AD.